Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
41.53B | 43.45B | 46.30B | 51.76B | 47.26B | Gross Profit |
9.38B | 9.60B | 9.91B | 11.64B | 10.57B | EBIT |
1.26B | 1.57B | 1.79B | 3.04B | 2.39B | EBITDA |
1.26B | 2.60B | 2.86B | 3.88B | 3.51B | Net Income Common Stockholders |
927.00M | 1.24B | 1.42B | 2.45B | 1.80B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.58B | 1.45B | 1.87B | 2.94B | 5.49B | Total Assets |
14.78B | 14.97B | 15.80B | 17.50B | 19.07B | Total Debt |
4.05B | 3.98B | 3.98B | 3.94B | 4.08B | Net Debt |
2.48B | 2.54B | 2.10B | 1.00B | -1.41B | Total Liabilities |
11.97B | 11.91B | 13.01B | 14.48B | 14.48B | Stockholders Equity |
2.81B | 3.05B | 2.79B | 3.02B | 4.59B |
Cash Flow | Free Cash Flow | |||
1.39B | 675.00M | 894.00M | 2.52B | 4.21B | Operating Cash Flow |
2.10B | 1.47B | 1.82B | 3.25B | 4.93B | Investing Cash Flow |
-704.00M | -781.00M | -962.00M | -1.37B | -788.00M | Financing Cash Flow |
-1.31B | -1.14B | -1.81B | -4.30B | -876.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $6.88B | 6.72 | 20.12% | 3.06% | -5.47% | -2.19% | |
66 Neutral | $17.92B | 16.51 | 53.91% | 1.57% | -0.50% | 24.11% | |
65 Neutral | $20.24B | 17.99 | 15.89% | 2.56% | 4.96% | -32.41% | |
61 Neutral | $15.67B | ― | 18.88% | ― | -9.88% | -205.57% | |
59 Neutral | $12.94B | 14.31 | 31.63% | 6.71% | -4.43% | -24.58% | |
59 Neutral | $10.97B | 9.83 | -1.56% | 4.06% | 1.31% | -16.49% | |
54 Neutral | $10.86B | 88.06 | 4.19% | ― | -27.50% | 1150.23% |